JD Supra1d
A Model’s Credibility Is in the Details: FDA Draft Guidance on the Use of AI Models in Drug and Biological Product Development
In January, the U.S. Food and Drug Administration (FDA) issued its first guidance on the use of artificial intelligence (AI) models in ...
C&EN7h
FDA approves drug for neurofibromatosis
The US Food and Drug Administration has approved mirdametinib for the treatment of neurofibromatosis type 1 (NF1) in adults ...
Conduit Pharmaceuticals Inc. (CDT) Advances AI-Driven Drug Development to Phase II
In this article, we are going to take a look at where Conduit Pharmaceuticals Inc. (NASDAQ:CDT) stands against the other AI ...
News Medical5d
New 3D bioprinted gastric cancer model predicts drug responses
A collaborative research team led by Professor Jinah Jang from the Department of Mechanical Engineering and the Department of ...
Chemistry World1d
Generative AI pipeline creates promising antimicrobial peptides
A new generative AI model rapidly generates diverse antimicrobial peptide structures for screening against ...
FierceBiotech1d
Conduit taps Charles River to build preclinical autoimmune case for AstraZeneca diabetes asset
Before taking its repurposed diabetes drug candidate into a phase 2 lupus trial, Conduit Pharmaceuticals is tapping Charles ...
NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...
Certis Oncology Announces Issuance of U.S. Patent for Its Proprietary CertisAI Predictive Oncology Intelligence™ Platform
Certis Oncology Solutions, a precision oncology and translational science company, announced today that the United States ...
labiotech1d
DeepMind AlphaFold’s alumnus raises $40m for Latent Labs, a new AI biotech startup
Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...
manilatimes1d
Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model
Conduit Pharmaceuticals partners with Charles River to evaluate the efficacy of its lead programme in a pre-clinical lupus model, utilizing Charles River's immunology expertise to refine study ...